CoChat

SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors

Published version of a preprint

The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.

Abstract

Failure of adoptive T-cell therapies in patients with cancer is linked to limited T-cell expansion and persistence, even in memory-prone 41BB-(BBz)–based chimeric antigen receptor (CAR) T cells. We show here that BBz-CAR T-cell stem/memory differentiation and persistence can be enhanced through epigenetic manipulation of the histone 3 lysine 9 trimethylation (H3K9me3) pathway. Inactivation of the H3K9 trimethyltransferase SUV39H1 enhances BBz-CAR T cell long-term persistence, protecting mice against tumor relapses and rechallenges in lung and disseminated solid tumor models up to several months after CAR T-cell infusion. Single-cell transcriptomic (single-cell RNA sequencing) and chromatin opening (single-cell assay for transposase accessible chromatin) analyses of tumor-infiltrating CAR T cells show early reprogramming into self-renewing, stemlike populations with decreased expression of dysfunction genes in all T-cell subpopulations. Therefore, epigenetic manipulation of H3K9 methylation by SUV39H1 optimizes the long-term functional persistence of BBz-CAR T cells, limiting relapses, and providing protection against tumor rechallenges. Significance: Limited CAR T-cell expansion and persistence hinders therapeutic responses in solid cancer patients. We show that targeting SUV39H1 histone methyltransferase enhances 41BB-based CAR T-cell long-term protection against tumor relapses and rechallenges by increasing stemness/memory differentiation. This opens a safe path to enhancing adoptive cell therapies for solid tumors. See related article by Jain et al., p. 142. This article is featured in Selected Articles from This Issue, p. 5

Overview

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-22-1350

Cites

68 of 68 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 68 references

Cited by

See all 72

Metadata

Authors
López-Cobo, S., Fuentealba, J. R., Gueguen, P., Bonté, P.-E., Tsalkitzi, K., Chacón, I., Glauzy, S., Bohineust, A., Biquand, A., Silva, L., Gouveia, Z., Goudot, C., Perez, F., Saitakis, M., & Amigorena, S.
Affiliations
  • 1Institut Curie, PSL University, Inserm U932, Immunity and Cancer, Paris, France.
  • Inserm (FR)
  • SIB Swiss Institute of Bioinformatics (CH)
  • Centre National de la Recherche Scientifique (FR)
  • 5Mnemo Therapeutics, Paris, France.
Venue
Cancer Discovery
Published
2023-10-31
Volume
14
Issue
1
Pages
120-141
ISSN
  • 2159-8274 (ISSN-L)
  • 2159-8290
OpenAlex
W4388454471
Cited by
72
References
68
Citations by year
2026: 28 · 2025: 18 · 2024: 26
FWCI
8.74
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Discovery (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
Funders
  • Agence Nationale de la Recherche (ANR-10-IDEX-0001-02 PSL, ANR-21-RHUS-0016)
  • Institut Curie (CIC IGR-Curie 1428)
Topics
  • Health Sciences › Medicine › Oncology › CAR-T cell therapy research
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
SUV39H1, H3K9 trimethylation, histone methyltransferase, chimeric antigen receptor T cells, 4-1BB, solid tumors, T cell persistence, tumor recurrence, tumor rechallenge, epigenetic reprogramming, stemness, memory differentiation, adoptive immunotherapy, lung cancer, disseminated cancer
MeSH terms
Receptors, Chimeric Antigen, Animals, Chromatin, Humans, Methyltransferases, Neoplasms, Recurrence, Repressor Proteins, Immunotherapy, Adoptive, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors. https://app.cochat.ai/papers/10.1158/2159-8290.cd-22-1350
The paper
López-Cobo, S., Fuentealba, J. R., Gueguen, P., Bonté, P.-E., Tsalkitzi, K., Chacón, I., Glauzy, S., Bohineust, A., Biquand, A., Silva, L., Gouveia, Z., Goudot, C., Perez, F., Saitakis, M., & Amigorena, S. (2024). SUV39H1 Ablation Enhances Long-term CAR T Function in Solid Tumors. Cancer Discovery. https://doi.org/10.1158/2159-8290.cd-22-1350

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.